|
Pfizer Faces More Lawsuits on Effexor XR Patents, Generic Competition
Pfizer is again facing lawsuits from pharmacies claiming it used fraudulent tactics to block and delay generic forms of its antidepressant Effexor XR.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives